FP7
PRO- ACTIVE
Physical Activity as a Crucial Patient Reported Outcome in COPD
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 81 months
- Total cost
- EUR 15,635,822
- EU contribution
- EUR 6,767,597
- Participants
- 18 from 9 countries
- Topic
- FP7_IMI-JU-01-2008-13
- Grant agreement
- 115011
Coordinated by Chiesi Farmaceutici SpA (ITItaly).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Chiesi Farmaceutici SpA | ITItaly | Coordinator | Not stated | PIC (1.00) |
| Katholieke Universiteit Leuven | BEBelgium | Participant | EUR 1,342,284 | PIC (1.00) |
| European Respiratory Society | CHSwitzerland | Participant | EUR 103,044 | PIC (1.00) |
| Novartis Pharma AG | CHSwitzerland | Participant | Not stated | PIC (1.00) |
| Universitat Zurich | CHSwitzerland | Participant | EUR 581,835 | known name (0.95) |
| Boehringer Ingelheim Internationalgmbh | DEGermany | Participant | Not stated | PIC (1.00) |
| Almirall SA | ESSpain | Participant | Not stated | PIC (1.00) |
| Fundacio Centre de Recerca en Epidemiologia Ambiental - Creal | ESSpain | Participant | EUR 274,525 | PIC (1.00) |
| Fundacio Institut Hospital del Mar D Investigacions Mediques | ESSpain | Participant | EUR 193,823 | known name (0.97) |
| British Lung Foundation | GBUnited Kingdom | Participant | EUR 66,090 | PIC (1.00) |
| Choice Healthcare solutions Ltd | GBUnited Kingdom | Participant | EUR 456,864 | PIC (1.00) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| Royal Brompton and Harefield National Health Service Trust | GBUnited Kingdom | Participant | EUR 1,076,742 | PIC (1.00) |
| The University of Edinburgh | GBUnited Kingdom | Participant | EUR 1,051,094 | known name (0.95) |
| Thorax Research Foundation | GRGreece | Participant | EUR 779,688 | PIC (1.00) |
| Academisch Ziekenhuis Groningen | NLNetherlands | Participant | EUR 606,270 | PIC (1.00) |
| Netherlands Asthma Foundation | NLNetherlands | Participant | EUR 235,338 | PIC (1.00) |
| Astrazeneca AB | SESweden | Participant | Not stated | PIC (1.00) |
Changes of the consortium
First seen on with 18 participants from 9 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.